VIKEN

About VIKEN

Viken Detection, headquartered in Burlington, Massachusetts, is a company specializing in the development and manufacturing of handheld x-ray imaging and analytical devices. Established in 2013, the firm was co-founded by Dr. H.S. Wasserman, who currently serves as the company's chairman. The company's inception was driven by a mission to create safer communities by providing law enforcement and security professionals with effective tools for detecting threats.

Viken Detection's product line is centered around handheld X-ray backscatter imagers and lead paint analyzers. A key offering is the HBI-120, a handheld X-ray imager that allows law enforcement and customs officials to quickly and safely find concealed contraband and explosives in vehicles, ships, and other locations without needing to physically dismantle them. The company also produces the FOX-C, a compact X-ray fluorescence (XRF) analyzer designed for the rapid detection of lead in paint, providing a critical tool for environmental and public health inspections. This technology is an evolution of the intellectual property acquired from Heuresis, which itself was a spin-out from Thermo Fisher Scientific.

The company's business model revolves around the sale of these specialized hardware devices to a client base that primarily includes federal and local law enforcement agencies, customs and border protection, and EOD (Explosive Ordnance Disposal) teams. Viken generates revenue through the direct sale of its products and likely through associated services such as training, maintenance, and software updates. The firm operates in the security and threat detection market, providing tools that enhance operational safety and efficiency for its clients.

A significant milestone for Viken Detection was the acquisition of Heuresis Corporation in 2016, which brought the core X-ray technology and key personnel, including Dr. Peter Rothschild, who became the CEO, into the fold. The company has received notable contracts, including a $2.5 million order from the U.S. Drug Enforcement Administration (DEA) and an award from U.S. Customs and Border Protection.